Patents Assigned to Muna Therapeutics ApS
  • TREM2 modulators
    Patent number: 12459953
    Abstract: The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells-2 (“TREM2”). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases, and to pharmaceutical compositions comprising the compounds.
    Type: Grant
    Filed: January 3, 2025
    Date of Patent: November 4, 2025
    Assignee: Muna Therapeutics ApS
    Inventors: Jakob Busch-Petersen, Gavin Whitlock
  • TREM2 modulators
    Patent number: 12459952
    Abstract: The present invention relates to compounds useful for modulating Triggering Receptor Expressed on Myeloid Cells-2 (“TREM2”). The invention also relates to the compounds for use in treatment of conditions related to loss of function of TREM2, such as neurodegenerative diseases, and to pharmaceutical compositions comprising the compounds.
    Type: Grant
    Filed: January 3, 2025
    Date of Patent: November 4, 2025
    Assignee: Muna Therapeutics ApS
    Inventors: Jakob Busch-Petersen, Gavin Whitlock